Literature DB >> 31408241

The Multidimensional Prognostic Index in general practice: One-year follow-up study.

Anna Maria Meyer1, Giacomo Siri2, Ingrid Becker3, Thomas Betz4, August W Bödecker5, Jörg W Robertz5, Olaf Krause6, Thomas Benzing1,7, Alberto Pilotto8,9, Maria Cristina Polidori1,7.   

Abstract

BACKGROUND: Older patients' health problems in general practice (GP) can often not be assigned to a specific disease, requiring a paradigm shift to goal-oriented, personalised care for clinical decision making.
PURPOSE: To investigate the predictive value of the comprehensive geriatric assessment (CGA)-based Multidimensional Prognostic Index (MPI) in a GP setting with respect to the main healthcare indicators during the 12 months following initial evaluation.
METHODS: One hundred twenty-five consecutive patients aged 70 years and older were enrolled in a GP and followed up to one year. All patients underwent a CGA based on which the MPI was calculated and subdivided into three risk groups (MPI-1, 0-0.33 = low risk, MPI-2, 0.34-0.66 = moderate risk and MPI-3, 0.67-1, severe risk). Grade of Care (GC), hospitalization rate, mortality, nursing home admission, use of home care services, falls, number of general practitioner contacts (GPC), of geriatric resources (GR) and geriatric syndromes (GS) during the 12 months following initial evaluation were collected.
RESULTS: The MPI was significantly associated with number of GS (P < .001), GR (P < .001), GC (P < .001) as well as with the average number of GPC per year (mean 10.4, P = .046). Interestingly, the clinical judgement of the general practitioner, in this case knowing his patients for 16 years on average, was associated with adverse outcomes to a similar extent than the prediction offered by the MPI (GP/adverse outcomes and MPI/adverse outcomes P < .001).
CONCLUSION: The MPI is strongly associated with adverse outcomes in older GP patients and strongly predicts the number of GPC up to one year after initial evaluation. Considering the feasibility and the strong clinimetric properties of the MPI, its collection should be encouraged as early as possible to disclose risk conditions, implement tailored preventive strategies and improve cost-effectiveness of healthcare resources use.
© 2019 John Wiley & Sons Ltd.

Entities:  

Year:  2019        PMID: 31408241     DOI: 10.1111/ijcp.13403

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  5 in total

1.  Multidimensional prognostic index (MPI) predicts successful application for disability social benefits in older people.

Authors:  Barbara Senesi; Camilla Prete; Giacomo Siri; Alessandra Pinna; Angela Giorgeschi; Nicola Veronese; Roberto Sulpasso; Carlo Sabbà; Alberto Pilotto
Journal:  Aging Clin Exp Res       Date:  2020-09-11       Impact factor: 3.636

Review 2.  A multidimensional approach to frailty in older people.

Authors:  Alberto Pilotto; Carlo Custodero; Stefania Maggi; Maria Cristina Polidori; Nicola Veronese; Luigi Ferrucci
Journal:  Ageing Res Rev       Date:  2020-03-21       Impact factor: 10.895

Review 3.  Using the Multidimensional Prognostic Index (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons: results and final recommendations from the MPI_AGE European Project.

Authors:  Alfonso J Cruz-Jentoft; Julia Daragjati; Laura Fratiglioni; Stefania Maggi; Arduino A Mangoni; Francesco Mattace-Raso; Marc Paccalin; Maria Cristina Polidori; Eva Topinkova; Luigi Ferrucci; Alberto Pilotto
Journal:  Aging Clin Exp Res       Date:  2020-03-16       Impact factor: 3.636

4.  The Multidimensional Prognostic Index as a Measure of Frailty in Elderly Patients with Head and Neck Cancer.

Authors:  Ajay T Bakas; Aniel Sewnaik; Jaclyn van Straaten; Robert J Baatenburg de Jong; Francesco U S Mattace-Raso; Harmke A Polinder-Bos
Journal:  Clin Interv Aging       Date:  2021-09-16       Impact factor: 4.458

5.  A rapid and feasible tool for clinical decision making in community-dwelling patients with COVID-19 and those admitted to emergency departments: the Braden-LDH-HorowITZ Assessment-BLITZ.

Authors:  Erik Lagolio; Jacopo Demurtas; Thomas Benzing; Maria Cristina Polidori; Roberto Buzzetti; Giorgio Cortassa; Stefania Bottone; Laura Spadafora; Cristina Cocino; Lee Smith
Journal:  Intern Emerg Med       Date:  2021-07-28       Impact factor: 5.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.